Table 3.

Adverse events according to type, severity (mild/moderate or severe/life threatening), and treatment group

Adverse EventStudy GroupsTotal
Intravenous MethylprednisolonePlasma Exchange
Mild/ModerateSevere/Life ThreateningMild/ModerateSevere/Life Threatening
Leukopenia (at least 1 episode)35735885
Recurrent leukopenia (>1 episode)13211430
Infection1317112061
Thrombocytopenia203510
Allergy406010
Cardiovascular23139
Diabetes32218
Gastrointestinal01326
Bone fracture02125
Thrombosis10135
Hemorrhage01113
Alopecia00202
Vascular access complication01012
Other13228
Totals74397952244
No.(%) of patients with ≥1 event59 (87)32 (48)63 (91)35 (50)122 (89)